Skip to main content

Table 3 Characteristics and response of metastatic lesions

From: A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases

Lesions Total (n = 139) %
Number of lesions:   
    Hepatic metastases 113 81%
    Lung metastases 26 19%
Lesion diameter, median (range):   
    Liver (n = 111) 28 mm (range 7–100)
    Lung (n = 26) 12.5 mm (range 5–63.5)
Previous local treatment to hepatic lesions 68 60%
Local hepatic treatment:   
    Surgery of same lesion 2 2%
    Surgery of other lesions 49 44%
    Chemo-embolisation 3 3%
    Radio-frequency 14 12%
Response (RECIST)   
Hepatic metastases   
     CR 56 51%
     PR 22 20%
     SD 10 9%
     PD 22 20%
Response   
Lung metastases   
     CR 14 58%
     PR 2 8%
     SD 1 4%
     PD 7 29%
Response   
All lesions   
CR 70 52%
PR 24 18%
SD 11 9%
PD 29 20%